Impact BioMedical Inc.
IBO
$0.8569
-$0.0731-7.86%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 579.03% | 7.80% | 22.11% | -6.28% | 9.36% |
| Total Depreciation and Amortization | 100.00% | -50.00% | 0.00% | 100.00% | -50.00% |
| Total Amortization of Deferred Charges | 0.36% | 0.00% | 0.00% | -0.36% | 0.36% |
| Total Other Non-Cash Items | -113,620.00% | 113.89% | -38.46% | -73.33% | -109.26% |
| Change in Net Operating Assets | -120.63% | -1,150.00% | -98.91% | 142.48% | 111.21% |
| Cash from Operations | -92.94% | 6.46% | -64.43% | 35.47% | 8.46% |
| Capital Expenditure | -- | -- | -- | 100.00% | 91.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -- | -- | -- | -100.00% |
| Cash from Investing | 0.00% | -- | -- | 200.00% | 90.91% |
| Total Debt Issued | -66.32% | -6.73% | 207.33% | -73.33% | 16.62% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 493.98% | -6.73% | 207.33% | -73.33% | 16.62% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -100.00% | 100.50% | -201.01% | 9,800.00% |
